TD Cowen analyst Ryan Langston maintains $Agilon Health (AGL.US)$ with a hold rating, and maintains the target price at $2.
According to TipRanks data, the analyst has a success rate of 55.9% and a total average return of 1.9% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Agilon Health (AGL.US)$'s main analysts recently are as follows:
Agilon Health's Q3 results highlight the challenges in gaining insight into current trends and the limited capacity to manage adverse events, according to an analyst.
The firm has revised its model post-Q3 results, indicating that intermediate liquidity issues could pose a risk, along with the possibility of further physician partner departures.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
